Balram Bhargava

InstitutionMinistry of Health & Family Welfare
AddressIndia
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 34 Covid-19 publications, with a maximum of 12 publications in July 2020
    All Publications
    Bar chart showing 79 publications over 19 distinct years, with a maximum of 15 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sapkal G, Yadav PD, Ella R, Abraham P, Patil DY, Gupta N, Panda S, Mohan VK, Bhargava B. Neutralization of VUI B.1.1.28 P2 variant with sera of COVID-19 recovered cases and recipients of Covaxin an inactivated COVID-19 vaccine. J Travel Med. 2021 10 11; 28(7). PMID: 34002240.
      Citations: 7     Fields:    Translation:Humans
    2. Yadav PD, Sapkal GN, Ella R, Sahay RR, Nyayanit DA, Patil DY, Deshpande G, Shete AM, Gupta N, Mohan VK, Abraham P, Panda S, Bhargava B. Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin. J Travel Med. 2021 10 11; 28(7). PMID: 34230972.
      Citations: 19     Fields:    Translation:Humans
    3. Sapkal GN, Yadav PD, Sahay RR, Deshpande G, Gupta N, Nyayanit DA, Patil DY, Shete AM, Kumar S, Abraham P, Panda S, Bhargava B. Neutralization of Delta variant with sera of Covishield™ vaccinees and COVID-19-recovered vaccinated individuals. J Travel Med. 2021 10 11; 28(7). PMID: 34343316.
      Citations: 2     Fields:    Translation:Humans
    4. Mandal S, Arinaminpathy N, Bhargava B, Panda S. India's pragmatic vaccination strategy against COVID-19: a mathematical modelling-based analysis. BMJ Open. 2021 07 02; 11(7):e048874. PMID: 34215611.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    5. Mandal S, Arinaminpathy N, Bhargava B, Panda S. Responsive and agile vaccination strategies against COVID-19 in India. Lancet Glob Health. 2021 09; 9(9):e1197-e1200. PMID: 34217378.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    6. Sapkal GN, Yadav PD, Ella R, Deshpande GR, Sahay RR, Gupta N, Vadrevu KM, Abraham P, Panda S, Bhargava B. Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2. J Travel Med. 2021 Jun 01; 28(4). PMID: 33772577.
      Citations: 14     Fields:    Translation:Humans
    7. Murhekar MV, Bhatnagar T, Thangaraj JWV, Saravanakumar V, Kumar MS, Selvaraju S, Rade K, Kumar CPG, Sabarinathan R, Turuk A, Asthana S, Balachandar R, Bangar SD, Bansal AK, Chopra V, Das D, Deb AK, Devi KR, Dhikav V, Dwivedi GR, Khan SMS, Kumar MS, Laxmaiah A, Madhukar M, Mahapatra A, Rangaraju C, Turuk J, Yadav R, Andhalkar R, Arunraj K, Bharadwaj DK, Bharti P, Bhattacharya D, Bhat J, Chahal AS, Chakraborty D, Chaudhury A, Deval H, Dhatrak S, Dayal R, Elantamilan D, Giridharan P, Haq I, Hudda RK, Jagjeevan B, Kalliath A, Kanungo S, Krishnan NN, Kshatri JS, Kumar A, Kumar N, Kumar VGV, Lakshmi GGJN, Mehta G, Mishra NK, Mitra A, Nagbhushanam K, Nimmathota A, Nirmala AR, Pandey AK, et al. SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020-January 2021. Int J Infect Dis. 2021 Jul; 108:145-155. PMID: 34022338.
      Citations: 12     Fields:    Translation:Humans
    8. Citations: 7     Fields:    Translation:Humans
    9. Kumar G, Mukherjee A, Sharma RK, Menon GR, Sahu D, Wig N, Panda S, Rao VV, Singh S, Guleria R, Bhargava B. Clinical profile of hospitalized COVID-19 patients in first & second wave of the pandemic: Insights from an Indian registry based observational study. Indian J Med Res. 2021 05; 153(5&6):619-628. PMID: 34259194.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    10. Mukherjee A, Anand T, Agarwal A, Singh H, Chatterjee P, Narayan J, Rana S, Gupta N, Bhargava B, Panda S. SARS-CoV-2 re-infection: development of an epidemiological definition from India. Epidemiol Infect. 2021 03 26; 149:e82. PMID: 33766185.
      Citations: 6     Fields:    Translation:Humans
    11. Ella R, Reddy S, Jogdand H, Sarangi V, Ganneru B, Prasad S, Das D, Raju D, Praturi U, Sapkal G, Yadav P, Reddy P, Verma S, Singh C, Redkar SV, Gillurkar CS, Kushwaha JS, Mohapatra S, Bhate A, Rai S, Panda S, Abraham P, Gupta N, Ella K, Bhargava B, Vadrevu KM. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial. Lancet Infect Dis. 2021 07; 21(7):950-961. PMID: 33705727.
      Citations: 66     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    12. Citations: 18     Fields:    Translation:AnimalsCells
    13. Murhekar MV, Bhatnagar T, Selvaraju S, Saravanakumar V, Thangaraj JWV, Shah N, Kumar MS, Rade K, Sabarinathan R, Asthana S, Balachandar R, Bangar SD, Bansal AK, Bhat J, Chopra V, Das D, Deb AK, Devi KR, Dwivedi GR, Khan SMS, Kumar CPG, Kumar MS, Laxmaiah A, Madhukar M, Mahapatra A, Mohanty SS, Rangaraju C, Turuk A, Baradwaj DK, Chahal AS, Debnath F, Haq I, Kalliath A, Kanungo S, Kshatri JS, Lakshmi GGJN, Mitra A, Nirmala AR, Prasad GV, Qurieshi MA, Sahay S, Sangwan RK, Sekar K, Shukla VK, Singh PK, Singh P, Singh R, Varma DS, Viramgami A, Panda S, Reddy DCS, Bhargava B. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey. Lancet Glob Health. 2021 03; 9(3):e257-e266. PMID: 33515512.
      Citations: 36     Fields:    Translation:Humans
    14. Ella R, Vadrevu KM, Jogdand H, Prasad S, Reddy S, Sarangi V, Ganneru B, Sapkal G, Yadav P, Abraham P, Panda S, Gupta N, Reddy P, Verma S, Kumar Rai S, Singh C, Redkar SV, Gillurkar CS, Kushwaha JS, Mohapatra S, Rao V, Guleria R, Ella K, Bhargava B. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect Dis. 2021 05; 21(5):637-646. PMID: 33485468.
      Citations: 76     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    15. Mohandas S, Yadav PD, Shete-Aich A, Abraham P, Vadrevu KM, Sapkal G, Mote C, Nyayanit D, Gupta N, Srinivas VK, Kadam M, Kumar A, Majumdar T, Jain R, Deshpande G, Patil S, Sarkale P, Patil D, Ella R, Prasad SD, Sharma S, Ella KM, Panda S, Bhargava B. Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model. iScience. 2021 Feb 19; 24(2):102054. PMID: 33521604.
      Citations: 28     
    16. Panda S, Kaur H, Dandona L, Bhargava B. Face mask - An essential armour in the fight of India against COVID-19. Indian J Med Res. 2021 Jan & Feb; 153(1 & 2):233-237. PMID: 33533732.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    17. Mukhopadhyay L, Yadav PD, Gupta N, Mohandas S, Patil DY, Shete-Aich A, Panda S, Bhargava B. Comparison of the immunogenicity & protective efficacy of various SARS-CoV-2 vaccine candidates in non-human primates. Indian J Med Res. 2021 Jan & Feb; 153(1 & 2):93-114. PMID: 33361645.
      Citations: 9     Fields:    Translation:Animals
    18. Krause PR, Fleming TR, Longini IM, Peto R, Beral V, Bhargava B, Cravioto A, Cramer JP, Ellenberg SS, Figueroa JP, Halloran E, Henao-Restrepo AM, Ryan MJ, Levine MM, Nason M, Nohynek HM, Plotkin S, Rees H, Singh JA, Swaminathan S. Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them. N Engl J Med. 2021 Jan 14; 384(2):e2. PMID: 33264543.
      Citations: 20     Fields:    Translation:Humans
    19. Chatterjee P, Anand T, Singh KJ, Rasaily R, Singh R, Das S, Singh H, Praharaj I, Gangakhedkar RR, Bhargava B, Panda S. Authors' response. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):120. PMID: 32773411.
      Citations:    Fields:    Translation:HumansPHPublic Health
    20. Chatterjee P, Anand T, Singh KJ, Rasaily R, Singh R, Das S, Singh H, Praharaj I, Gangakhedkar RR, Bhargava B, Panda S. Authors' response. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):122-123. PMID: 32773413.
      Citations:    Fields:    Translation:HumansPHPublic Health
    21. Chatterjee P, Anand T, Singh KJ, Rasaily R, Singh R, Das S, Singh H, Praharaj I, Gangakhedkar RR, Bhargava B, Panda S. Authors' response. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):117-118. PMID: 32773416.
      Citations:    Fields:    Translation:HumansPHPublic Health
    22. Chatterjee P, Anand T, Singh KJ, Rasaily R, Singh R, Das S, Singh H, Praharaj I, Gangakhedkar RR, Bhargava B, Panda S. Authors' response. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):138-140. PMID: 32773419.
      Citations:    Fields:    Translation:HumansPHPublic Health
    23. Chatterjee P, Anand T, Singh KJ, Rasaily R, Singh R, Das S, Singh H, Praharaj I, Gangakhedkar RR, Bhargava B, Panda S. Authors' response. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):141. PMID: 32773423.
      Citations:    Fields:    Translation:HumansPHPublic Health
    24. Chatterjee P, Anand T, Singh KJ, Rasaily R, Singh R, Das S, Singh H, Praharaj I, Gangakhedkar RR, Bhargava B, Panda S. Authors' response. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):135-136. PMID: 32773425.
      Citations:    Fields:    Translation:HumansPHPublic Health
    25. Chatterjee P, Anand T, Singh KJ, Rasaily R, Singh R, Das S, Singh H, Praharaj I, Gangakhedkar RR, Bhargava B, Panda S. Authors' response. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):144-145. PMID: 32773427.
      Citations:    Fields:    Translation:HumansPHPublic Health
    26. Chatterjee P, Anand T, Singh KJ, Rasaily R, Singh R, Das S, Singh H, Praharaj I, Gangakhedkar RR, Bhargava B, Panda S. Authors' response. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):128-129. PMID: 32773429.
      Citations:    Fields:    Translation:HumansPHPublic Health
    27. Chatterjee P, Anand T, Singh KJ, Rasaily R, Singh R, Das S, Singh H, Praharaj I, Gangakhedkar RR, Bhargava B, Panda S. Authors' response. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):125-126. PMID: 32801225.
      Citations:    Fields:    Translation:HumansPHPublic Health
    28. Chatterjee P, Anand T, Singh KJ, Rasaily R, Singh R, Das S, Singh H, Praharaj I, Gangakhedkar RR, Bhargava B, Panda S. Authors' response. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):147-148. PMID: 32801227.
      Citations:    Fields:    Translation:HumansPHPublic Health
    29. Chatterjee P, Anand T, Singh KJ, Rasaily R, Singh R, Das S, Singh H, Praharaj I, Gangakhedkar RR, Bhargava B, Panda S. Authors' response. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):132-133. PMID: 32811799.
      Citations:    Fields:    Translation:HumansPHPublic Health
    30. Murhekar MV, Bhatnagar T, Selvaraju S, Rade K, Saravanakumar V, Vivian Thangaraj JW, Kumar MS, Shah N, Sabarinathan R, Turuk A, Anand PK, Asthana S, Balachandar R, Bangar SD, Bansal AK, Bhat J, Chakraborty D, Rangaraju C, Chopra V, Das D, Deb AK, Devi KR, Dwivedi GR, Salim Khan SM, Haq I, Kumar MS, Laxmaiah A, Mahapatra A, Mitra A, Nirmala AR, Pagdhune A, Qurieshi MA, Ramarao T, Sahay S, Sharma YK, Shrinivasa MB, Shukla VK, Singh PK, Viramgami A, Wilson VC, Yadav R, Girish Kumar CP, Luke HE, Ranganathan UD, Babu S, Sekar K, Yadav PD, Sapkal GN, Das A, Das P, Dutta S, Hemalatha R, Kumar A, Narain K, Narasimhaiah S, Panda S, Pati S, Patil S, Sarkar K, Singh S, et al. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):48-60. PMID: 32952144.
      Citations: 60     Fields:    Translation:HumansCellsPHPublic Health
    31. Vivian Thangaraj JW, Murhekar M, Mehta Y, Kataria S, Brijwal M, Gupta N, Choudhary A, Malhotra B, Vyas M, Sharma H, Yadav N, Bhatnagar T, Gupta N, Dar L, Gangakhedkar RR, Bhargava B. A cluster of SARS-CoV-2 infection among Italian tourists visiting India, March 2020. Indian J Med Res. 2020 May; 151(5):438-443. PMID: 32474558.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    32. Chatterjee P, Anand T, Singh KJ, Rasaily R, Singh R, Das S, Singh H, Praharaj I, Gangakhedkar RR, Bhargava B, Panda S. Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19. Indian J Med Res. 2020 May; 151(5):459-467. PMID: 32611916.
      Citations: 79     Fields:    Translation:HumansCellsPHPublic Health
    33. Cherian SS, Agrawal M, Basu A, Abraham P, Gangakhedkar RR, Bhargava B. Perspectives for repurposing drugs for the coronavirus disease 2019. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):160-171. PMID: 32317408.
      Citations: 20     Fields:    Translation:HumansCellsPHPublic Health
    34. Gupta N, Praharaj I, Bhatnagar T, Vivian Thangaraj JW, Giri S, Chauhan H, Kulkarni S, Murhekar M, Singh S, Gangakhedkar RR, Bhargava B. Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):236-240. PMID: 32362647.
      Citations: 24     Fields:    Translation:HumansCellsPHPublic Health
    Bhargava's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (183)
    Explore
    _
    Co-Authors (315)
    Explore
    _
    Similar People (60)
    Explore
    _